VSIG4 and lymphoma: Our study revealed that in VSIG4-deficiency mice bearing lymphoma, a model widely used in immunotherapy and tumor microenvironment study [51, 52], the frequency of tumor-infiltrating CD8+ T and NK cells was evidently increased, and neutrophils as well as Tregs were profoundly decreased.